Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Can Diagnostic and Therapeutic Arthrocentesis Be Successfully Performed in the Flexed Knee?

Yaqub S, Sibbitt WL Jr, Band PA, Bennett JF, Emil NS, Fangtham M, Fields RA, Hayward WA, Kettwich SK, Roldan LP, Bankhurst AD.

J Clin Rheumatol. 2018 Sep;24(6):295-301. doi: 10.1097/RHU.0000000000000707.

PMID:
29424762
2.

TSG-6 - a double-edged sword for osteoarthritis (OA).

Chou CH, Attarian DE, Wisniewski HG, Band PA, Kraus VB.

Osteoarthritis Cartilage. 2018 Feb;26(2):245-254. doi: 10.1016/j.joca.2017.10.019. Epub 2017 Nov 9.

3.

Improvement in diagnostic and therapeutic arthrocentesis via constant compression.

Bhavsar TB, Sibbitt WL Jr, Band PA, Cabacungan RJ, Moore TS, Salayandia LC, Fields RA, Kettwich SK, Roldan LP, Suzanne Emil N, Fangtham M, Bankhurst AD.

Clin Rheumatol. 2018 Aug;37(8):2251-2259. doi: 10.1007/s10067-017-3836-x. Epub 2017 Sep 14.

PMID:
28913649
4.

Engineering Botulinum Neurotoxin C1 as a Molecular Vehicle for Intra-Neuronal Drug Delivery.

Vazquez-Cintron EJ, Beske PH, Tenezaca L, Tran BQ, Oyler JM, Glotfelty EJ, Angeles CA, Syngkon A, Mukherjee J, Kalb SR, Band PA, McNutt PM, Shoemaker CB, Ichtchenko K.

Sci Rep. 2017 Feb 21;7:42923. doi: 10.1038/srep42923.

5.

Feasibility of integrating standardized patient-reported outcomes in orthopedic care.

Slover JD, Karia RJ, Hauer C, Gelber Z, Band PA, Graham J.

Am J Manag Care. 2015 Aug;21(8):e494-500.

PMID:
26625504
6.

Using Medicare data to understand health care value: measures of incremental cost and effectiveness are both needed to estimate value.

Band PA.

JAMA Intern Med. 2015 Mar;175(3):462. doi: 10.1001/jamainternmed.2014.7189. No abstract available.

PMID:
25730566
7.

Hyaluronan molecular weight distribution is associated with the risk of knee osteoarthritis progression.

Band PA, Heeter J, Wisniewski HG, Liublinska V, Pattanayak CW, Karia RJ, Stabler T, Balazs EA, Kraus VB.

Osteoarthritis Cartilage. 2015 Jan;23(1):70-6. doi: 10.1016/j.joca.2014.09.017. Epub 2014 Oct 7.

8.

Atoxic derivative of botulinum neurotoxin A as a prototype molecular vehicle for targeted delivery to the neuronal cytoplasm.

Vazquez-Cintron EJ, Vakulenko M, Band PA, Stanker LH, Johnson EA, Ichtchenko K.

PLoS One. 2014 Jan 22;9(1):e85517. doi: 10.1371/journal.pone.0085517. eCollection 2014.

9.

TSG-6 activity as a novel biomarker of progression in knee osteoarthritis.

Wisniewski HG, Colón E, Liublinska V, Karia RJ, Stabler TV, Attur M, Abramson SB, Band PA, Kraus VB.

Osteoarthritis Cartilage. 2014 Feb;22(2):235-41. doi: 10.1016/j.joca.2013.12.004. Epub 2013 Dec 12.

10.

Basic principles for conducting human research in orthopaedic medicine.

Slover JD, Shue J, Karia RJ, Band PA.

J Am Acad Orthop Surg. 2013 Jun;21(6):364-71. doi: 10.5435/JAAOS-21-06-364. Review.

PMID:
23728961
11.

Does ultrasound guidance improve the outcomes of arthrocentesis and corticosteroid injection of the knee?

Sibbitt WL Jr, Kettwich LG, Band PA, Chavez-Chiang NR, DeLea SL, Haseler LJ, Bankhurst AD.

Scand J Rheumatol. 2012 Feb;41(1):66-72. doi: 10.3109/03009742.2011.599071. Epub 2011 Nov 21.

PMID:
22103390
12.

A randomized controlled trial evaluating the cost-effectiveness of sonographic guidance for intra-articular injection of the osteoarthritic knee.

Sibbitt WL Jr, Band PA, Kettwich LG, Chavez-Chiang NR, Delea SL, Bankhurst AD.

J Clin Rheumatol. 2011 Dec;17(8):409-15. doi: 10.1097/RHU.0b013e31823a49a4.

PMID:
22089991
13.

Safety syringes and anti-needlestick devices in orthopaedic surgery.

Sibbitt WL Jr, Band PA, Kettwich LG, Sibbitt CR, Sibbitt LJ, Bankhurst AD.

J Bone Joint Surg Am. 2011 Sep 7;93(17):1641-9. doi: 10.2106/JBJS.J.01255.

PMID:
21915580
14.

The highly accurate anteriolateral portal for injecting the knee.

Chavez-Chiang CE, Sibbitt WL Jr, Band PA, Chavez-Chiang NR, DeLea SL, Bankhurst AD.

Sports Med Arthrosc Rehabil Ther Technol. 2011 Mar 30;3(1):6. doi: 10.1186/1758-2555-3-6.

15.

Neuronal targeting, internalization, and biological activity of a recombinant atoxic derivative of botulinum neurotoxin A.

Pellett S, Tepp WH, Stanker LH, Band PA, Johnson EA, Ichtchenko K.

Biochem Biophys Res Commun. 2011 Feb 25;405(4):673-7. doi: 10.1016/j.bbrc.2011.01.093. Epub 2011 Feb 1.

16.

The outcomes and cost-effectiveness of intraarticular injection of the rheumatoid knee.

Chavez-Chiang NR, Sibbitt WL, Band PA, DeLea SL, Park KS, Bankhurst AD.

Rheumatol Int. 2012 Feb;32(2):513-8. doi: 10.1007/s00296-010-1718-5. Epub 2011 Jan 21.

PMID:
21253739
17.

A randomized controlled trial of the cost-effectiveness of ultrasound-guided intraarticular injection of inflammatory arthritis.

Sibbitt WL Jr, Band PA, Chavez-Chiang NR, Delea SL, Norton HE, Bankhurst AD.

J Rheumatol. 2011 Feb;38(2):252-63. doi: 10.3899/jrheum.100866. Epub 2010 Nov 15.

PMID:
21078710
18.

OARSI update on the evidence for osteoarthritis therapies: comment on the nomenclature used for intra-articular hyaluronan.

Band PA.

Osteoarthritis Cartilage. 2010 Sep;18(9):1235; author reply 1236. doi: 10.1016/j.joca.2010.03.019. Epub 2010 Jul 13. No abstract available.

19.

Recombinant derivatives of botulinum neurotoxin A engineered for trafficking studies and neuronal delivery.

Band PA, Blais S, Neubert TA, Cardozo TJ, Ichtchenko K.

Protein Expr Purif. 2010 May;71(1):62-73. doi: 10.1016/j.pep.2009.12.013. Epub 2010 Jan 4.

20.

Platelet-rich plasma: current concepts and application in sports medicine.

Hall MP, Band PA, Meislin RJ, Jazrawi LM, Cardone DA.

J Am Acad Orthop Surg. 2009 Oct;17(10):602-8. Review. Erratum in: J Am Acad Orthop Surg. 2010 Jan;18(1):17A.

PMID:
19794217
21.

Does sonographic needle guidance affect the clinical outcome of intraarticular injections?

Sibbitt WL Jr, Peisajovich A, Michael AA, Park KS, Sibbitt RR, Band PA, Bankhurst AD.

J Rheumatol. 2009 Sep;36(9):1892-902. doi: 10.3899/jrheum.090013. Epub 2009 Jul 31.

PMID:
19648304
22.

Transfer of inter-alpha-inhibitor heavy chains to hyaluronan by surface-linked hyaluronan-TSG-6 complexes.

Colón E, Shytuhina A, Cowman MK, Band PA, Sanggaard KW, Enghild JJ, Wisniewski HG.

J Biol Chem. 2009 Jan 23;284(4):2320-31. doi: 10.1074/jbc.M807183200. Epub 2008 Nov 25.

23.

An integrated analysis of five double-blind, randomized controlled trials evaluating the safety and efficacy of a hyaluronan product for intra-articular injection in osteoarthritis of the knee.

Strand V, Conaghan PG, Lohmander LS, Koutsoukos AD, Hurley FL, Bird H, Brooks P, Day R, Puhl W, Band PA.

Osteoarthritis Cartilage. 2006 Sep;14(9):859-66. Epub 2006 Apr 19.

24.
25.

Intra-articular hyaluronic acid for treatment of osteoarthritis of the knee.

Band PA.

JAMA. 2004 Mar 24;291(12):1440; author reply 1441-2. No abstract available.

PMID:
15039403
26.

A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 2 of 2): economic results.

Torrance GW, Raynauld JP, Walker V, Goldsmith CH, Bellamy N, Band PA, Schultz M, Tugwell P; Canadian Knee OA Study Group.

Osteoarthritis Cartilage. 2002 Jul;10(7):518-27.

27.

A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 1 of 2): clinical results.

Raynauld JP, Torrance GW, Band PA, Goldsmith CH, Tugwell P, Walker V, Schultz M, Bellamy N; Canadian Knee OA Study Group.

Osteoarthritis Cartilage. 2002 Jul;10(7):506-17.

28.

Enhanced substantivity of hyaluronic acid on keratin substrates via polymer complexation.

Pavlichko JP, Goddard ED, Band PA, Leschiner A.

Int J Cosmet Sci. 1994 Dec;16(6):227-34. doi: 10.1111/j.1467-2494.1994.tb00099.x.

PMID:
19250478

Supplemental Content

Support Center